|
PSMC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.237000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.484100E-03 |
| Normal-vs-Stage2 |
3.522800E-01 |
| Normal-vs-Stage3 |
3.185100E-04 |
| Normal-vs-Stage4 |
3.440300E-03 |
| Stage1-vs-Stage2 |
4.795600E-01 |
| Stage1-vs-Stage3 |
1.341780E-01 |
| Stage1-vs-Stage4 |
1.601370E-01 |
| Stage2-vs-Stage3 |
1.405000E-01 |
| Stage2-vs-Stage4 |
1.180400E-01 |
| Stage3-vs-Stage4 |
6.401400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.576600E-04 |
| Normal-vs-AfricanAmerican |
1.202190E-01 |
| Normal-vs-Asian |
1.357620E-01 |
| Caucasian-vs-AfricanAmerican |
5.586800E-01 |
| Caucasian-vs-Asian |
3.519200E-01 |
| AfricanAmerican-vs-Asian |
9.144000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.029900E-04 |
| Normal-vs-Female |
2.979700E-03 |
| Male-vs-Female |
2.118200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.562040E-02 |
| Normal-vs-Age(41-60Yrs) |
8.381600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.080100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.337040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.649000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.961830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.243800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.154200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.851400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.615600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.136000E-02 |
| Classical-VS-Follicular |
3.561000E-01 |
| Classical-VS-Other |
1.367780E-01 |
| Classical-VS-Normal |
8.877800E-03 |
| Tall-VS-Follicular |
3.612600E-01 |
| Tall-VS-Other |
3.897000E-01 |
| Tall-VS-Normal |
4.784600E-04 |
| Follicular-VS-Other |
3.211600E-01 |
| Follicular-VS-Normal |
8.622900E-03 |
| Other-VS-Normal |
4.015700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.587600E-04 |
| Normal-vs-N1 |
6.097300E-03 |
| N0-vs-N1 |
4.144400E-01 |
|
|
